Location [1]
Protein [2]
Unconventional myosin-Va
Synonyms [1]
MYH12, MYR12, GS1, MYO5

MYO5A is altered in 0.12% of all cancers with lung adenocarcinoma, breast invasive ductal carcinoma, dedifferentiated liposarcoma, colon adenocarcinoma, and anaplastic ganglioglioma having the greatest prevalence of alterations [3].

MYO5A GENIE Cases - Top Diseases

The most common alterations in MYO5A are MYO5A-ROS1 Fusion (0.10%) and MYO5A-NTRK3 Fusion (0.03%) [3].

MYO5A GENIE Cases - Top Alterations


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.